Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Answer: Can you identify this condition?

Sergio Vano-Galvan, Mayte Truchuelo and Pedro Jaén
Canadian Family Physician August 2009, 55 (8) 807;
Sergio Vano-Galvan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mayte Truchuelo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Jaén
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Answer to Dermacase continued from page 805

2. Mediterranean spotted fever

Based on a presumptive diagnosis of Mediterranean spotted fever (MSF), our patient was treated with 100 mg of doxycycline twice daily for 10 days. After 2 days of antibiotic therapy, the fever, rash, and abnormal laboratory results began to improve. The first serologic test results were negative, but 2 weeks later the clinical diagnosis was confirmed by an immunoglobulin G (1:125) and immunoglobulin M (> 1:125) test positive for Rickettsia conorii.

Mediterranean spotted fever, also called boutonneuse fever, fièvre boutonneuse, or Marseilles fever, is an acute, febrile, tick-transmitted rickettsiosis caused by R conorii, an obligate intracellular bacterium. The disease is endemic in many countries surrounding the Mediterranean Sea, so physicians should suspect it in travelers returning from these areas. It is transmitted to humans by the brown dog tick Rhipicephalus sanguineus, which is generally considered to be the most common tick in the Mediterranean area.1 Diagnosis is based on clinical findings early in the course of the disease; MSF should be suspected in patients presenting with fever of 39.8ºC or higher, a so-called tache noire (an eschar that appears at the site of the tick inoculation of rickettsiae), and a nonpruritic maculopapular rash.

Epidemiology

Mediterranean spotted fever affects all races and ages, and the male-to-female ratio is 1.7:1. The disease is widely distributed in India, Africa, Europe, and Middle Eastern areas bordering the Mediterranean, sub-Saharan Africa, and around the Black and Caspian seas.2 Most cases are diagnosed between June and September (during the reproduction cycle of Rhipicephalus species); however, MSF might be easily misdiagnosed in patients outside the areas of endemicity or during the winter.3

Clinical findings

After an incubation period of around 7 days, MSF manifests abruptly with chills, high fever (39ºC to 41ºC), myalgia, arthralgia, severe headache, and photophobia.2 Half of patients have a tache noire at the site of the tick inoculation of rickettsiae. Around the third to sixth day of illness, a nonpruritic exanthem (widespread rash) appears, first macular, then maculopapular, and sometimes petechial. In some, the only sign is an isolated lymphadenopathy.

Diagnosis

Diagnosis of rickettsiosis is based on clinical and epidemiologic criteria, such as signs, symptoms, and potential tick exposure. Serologic diagnosis is usually retrospective, as antibodies do not develop until day 7 or later.

Rickettsiae can be identified by immunofluorescence or immunohistochemistry during biopsy of an eschar or a maculopapular lesion. Laboratory workup does not usually contribute to diagnosis in acute patients, although characteristic abnormalities include left shift in white blood cells, relative leukopenia (sometimes leukocytosis) and thrombocytopenia, increased aspartate aminotransferase and lactate dehydrogenase levels, and hyponatremia.

Before onset of the rash, differential diagnoses can include typhoid fever, ehrlichiosis, and many viral infections with similar nonspecific symptoms. In early stages the rash is often confused with a drug rash. Physicians should suspect rickettsiosis in patients returning from nonendemic areas with travel-associated fever. Known history of contact with dogs can be of considerable help.

Treatment

Antibiotics are the mainstay of therapy. Tetracyclines are the drugs of choice and should be prescribed whenever a case of rickettsiosis is suspected. Doxycycline (100 mg twice daily for 10 days) is the most commonly used regimen in adults. Clarithromycin can be a valid alternative to tetracyclines in children, especially for those younger than 8 years of age.1 The fever decreases and the rash usually disappears after 2 to 4 days of first-line therapy.

Prevention

After exposure to tick-infested areas, individuals should check their entire bodies, including all hairy parts of the body, for tick infestation. A helper should inspect less visible areas, such as the scalp and the back; a mirror can also be used for this purpose. To remove a tick from the skin, grasp the apical part of the tick with forceps and pull it out in an upward motion. There is no need to treat the tick with toxic substances, alcoholic solvents, or hot objects (such as cigarettes). Removal of ticks with the fingernails is not advised, as it could be dangerous if the tick is infested with rickettsiae and is squashed during removal.2

Dogs should also be inspected for ticks after each trip to a forest or rural area. The face, the area in and around the ears, the neck, and the space between the toes should be carefully examined. Individual ticks should be removed with forceps. Heavily infested dogs should be treated with an acaricidal shampoo or powder containing carbaryl.

Complications

Prognosis is very good in mild cases. Complications occur mainly in patients who are immunocompromised or elderly and include renal failure (mainly due to renal vasculitis, acute tubular necrosis, or perivascular interstitial glomerulonephritis), respiratory failure, gastrointestinal bleeding, stroke, deep venous thrombosis, arthromyalgia, meningoencephalitic involvement, and myelitis.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    ColombaCSaporitoLPolaraVFRubinoRTitoneLMediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian childrenBMC Infect Dis2006660
    OpenUrlCrossRefPubMed
  2. ↵
    MumcuogluKYKeysaryAGileadLMediterranean spotted fever in Israel: a tick-borne diseaseIsr Med Assoc J200241449
    OpenUrlPubMed
  3. ↵
    MertAOzarasRTabakFBilirMOzturkRMediterranean spotted fever: a review of fifteen casesJ Dermatol20063321037
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 55 (8)
Canadian Family Physician
Vol. 55, Issue 8
1 Aug 2009
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Answer: Can you identify this condition?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Answer: Can you identify this condition?
Sergio Vano-Galvan, Mayte Truchuelo, Pedro Jaén
Canadian Family Physician Aug 2009, 55 (8) 807;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Answer: Can you identify this condition?
Sergio Vano-Galvan, Mayte Truchuelo, Pedro Jaén
Canadian Family Physician Aug 2009, 55 (8) 807;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • 2. Mediterranean spotted fever
    • Epidemiology
    • Clinical findings
    • Diagnosis
    • Treatment
    • Prevention
    • Complications
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • Question: Can you identify this condition?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Is 45 the new 50 in colorectal cancer screening?
  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
Show more Practice

Dermacase

  • Question: Can you identify this condition?
  • Answer: Can you identify this condition?
  • Question: Can you identify this condition?
Show more Dermacase

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire